# The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients

> **NCT06539663** · PHASE2,PHASE3 · COMPLETED · sponsor: **Farwaniya Hospital** · enrollment: 5 (actual)

## Conditions studied

- Corneal Perforation
- Exposure Keratitis
- Infectious Keratitis

## Interventions

- **COMBINATION_PRODUCT:** OmniLenz®

## Key facts

- **NCT ID:** NCT06539663
- **Lead sponsor:** Farwaniya Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-10
- **Primary completion:** 2024-02-10
- **Final completion:** 2024-04-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06539663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06539663, "The Role of OmniLenz® in the Treatment of Small Corneal Perforations Secondary to Exposure Keratitis in ICU Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06539663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*